Study Contributors

COVIDRIVE’s Study Contributors network consists of 29 study sites from 14 different European countries: Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Iceland, Italy, Netherlands, Poland, Romania, Spain and the United Kingdom. Our network includes more than 55 hospitals, 5 primary care networks and a nation-wide register in Finland
COVIDRIVE Study Contributors network (as of 30th of November of 2022)

COVIDRIVE is open to include new study sites in its European network. For more information on how to join COVIDRIVE, please see section “Participate

  • Centro Interuniversitario per la Ricerca sull’Influenza e le altre Infezioni Trasmissibili (CIRI-IT, Italy)
  • COVIREIVAC hospital network, France
  • Finnish Institute for Health and Welfare (THL, Finland)
  • Fisabio VAHNSI hospital network (Spain)
  • Hospital Universitario de Salamanca (Spain)
  • Hospital Universitario Germans Trias i Pujol (Spain)
  • Hospital Universitario La Paz (Spain)
  • Grand Hôpital de Charleroi (Belgium)
  • University Hospital Antwerp (UZA, Belgium)
  • GZIM GP network (Germany)
  • Forum Impfen GP network (Germany)
  • Uniklinikum Freiburg (Germany)
  • Hospital Universitario Vall d’Hebron and Hospital Universitario Josep Trueta (Spain)
  • Iceland Directorate of Health (Iceland)
  • Imperial College London Health Partners (United Kingdom)
  • Klinik Favoriten Hospital (Austria)
  • LOGEX (Netherlands)
  • National Institute for Infectious Diseases, “Prof. Dr. Matei Bals” (Romania)
  • National Institute of Public Health (Poland)
  • North West E-health (United Kingdom)
  • BREATHE consortium (United Kingdom) 
  • University Hospital Ghent (Belgium)
  • CHU Saint Pierre Hospital Brussels (Belgium)
  • Hospital Fran Mihaljevic Zagreb (Croatia)
  • Universitätsklinikum Frankfurt (Germany)
  • Universitätsklinikum Ulm (Germany)
  • Universitätsklinikum Köln – DZIF (Germany)
  • Aarhus University Hospital (Denmark)
  • Odense University Hospital (Denmark)